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India leads the world with largest number of diabetic subjects earning the dubious distinction of
being termed the “diabetes capital of the world”. According to the Diabetes Atlas 2006 published
by the International Diabetes Federation, the number of people with diabetes in India currently
around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are
taken. The so called “Asian Indian Phenotype” refers to certain unique clinical and biochemical
abnormalities in Indians which include increased insulin resistance, greater abdominal adiposity
i.e., higher waist circumference despite lower body mass index, lower adiponectin and higher high
sensitive C-reactive protein levels. This phenotype makes Asian Indians more prone to diabetes
and premature coronary artery disease. At least a part of this is due to genetic factors. However,
the primary driver of the epidemic of diabetes is the rapid epidemiological transition associated
with changes in dietary patterns and decreased physical activity as evident from the higher
prevalence of diabetes in the urban population. Even though the prevalence of microvascular
complications of diabetes like retinopathy and nephropathy are comparatively lower in Indians,
the prevalence of premature coronary artery disease is much higher in Indians compared to other
ethnic groups. The most disturbing trend is the shift in age of onset of diabetes to a younger age in
the recent years. This could have long lasting adverse effects on nation’s health and economy.
Early identification of at-risk individuals using simple screening tools like the Indian Diabetes
Risk Score (IDRS) and appropriate lifestyle intervention would greatly help in preventing or
postponing the onset of diabetes and thus reducing the burden on the community and the nation as
a whole.
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The prevalence of diabetes is rapidly rising all
over the globe at an alarming rate1. Over the past
30 yr, the status of diabetes has changed from being
considered as a mild disorder of the elderly to one
of the major causes of morbidity and mortality
affecting the youth and middle aged people. It is
important to note that the rise in prevalence is seen
in all six inhabited continents of the globe2. Although
there is an increase in the prevalence of type 1
diabetes also, the major driver of the epidemic is the
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more common form of diabetes, namely type 2
diabetes, which accounts for more than 90 per cent
of all diabetes cases.
Nowhere is the diabetes epidemic more
pronounced than in India as the World Health
Organization (WHO) reports show that 32 million
people had diabetes in the year 2000 2. The
International Diabetes Federation (IDF) estimates the
total number of diabetic subjects to be around 40.9
million in India and this is further set to rise to 69.9
million by the year 20253 (Fig. 1).
Evolution of the diabetes epidemic in India
The first national study on the prevalence of type
2 diabetes in India was done between 1972 and 1975
by the Indian Council Medical Research (ICMR, New
Delhi)4. Screening was done in about 35,000
individuals above 14 yr of age, using 50 g glucose
load. Capillary blood glucose level >170 mg/dl was
used to diagnose diabetes. The prevalence was 2.1
per cent in urban population and 1.5 per cent in the
rural population while in those above 40 yr of age,
the prevalence was 5 per cent in urban and 2.8 per
cent in rural areas.
Subsequent studies showed a rising trend in the
prevalence of diabetes across different parts of India.
In 1988, a study done in a small township in south
India reported a prevalence of 5 per cent5. The
prevalence of impaired glucose tolerance in the same
study was 2 per cent. A national rural diabetes survey
was done between 1989 and 1991 in different parts of
the country in selected rural populations6. This study
which used the 1985 WHO criteria to diagnose
diabetes, reported a crude prevalence of 2.8 per cent6.
The Eluru survey which looked at the prevalence of
known diabetes in four villages in Andhra Pradesh
showed a prevalence of 1.5 per cent. The prevalence
of known diabetes was 6.1 per cent in individuals aged
above 40 yr which was unexpectedly high at that time
for a rural area with low socio-economic status and
decreased health awareness7. A study done in 1988 in
Chennai reported a prevalence of 8.2 per cent in the
urban and 2.4 per cent in the rural areas8. A subsequent
Fig. 1. Estimated number of diabetic subjects in India.
Source: Ref. 2, 3.
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study in the same urban area done after five years
showed an age standardized prevalence of 11.6 per
cent indicating a rising trend in prevalence of diabetes9.
A very high prevalence of 16.3 per cent was reported
in Thiruvanathapuram in Kerala State in the year
199910. In the same year, a prevalence of 8.2 per cent
was reported from Guwahati11. A cross-sectional
population survey was done in the Kashmir valley in
2000 and the prevalence of ‘known diabetes’ among
adults aged >40 yr was found to be 1.9 per cent12.
The National Urban Diabetes Survey (NUDS), a
population based study was conducted in six
metropolitan cities across India and recruited 11,216
subjects aged 20 yr and above representative of all
socio-economic strata13. An oral glucose tolerance
test was done using capillary glucose and diabetes
was defined using the WHO criteria14. The study
reported that the age standardized prevalence of type
2 diabetes was 12.1 per cent. This study also revealed
that the prevalence in the southern part of India to
be higher-13.5 per cent in Chennai, 12.4 per cent, in
Bangalore, and 16.6 per cent Hyderabad; compared
to eastern India (Kolkatta), 11.7 per cent; northern
India (New Delhi), 11.6 per cent; and western India
(Mumbai), 9.3 per cent. The study also suggested that
there was a large pool of subjects with impaired
glucose tolerance (IGT), 14 per cent with a high risk
of conversion to diabetes.
A study done in western India showed age-
standardized prevalence of 8.6 per cent in urban
population15. A more recent study reported a high
prevalence (9.3%) in rural Maharashtra16. The Amrita
Fig. 2. Recent population based studies showings the prevalence of type 2 diabetes in different parts of India.
Source: Ref. 10, 11, 12, 13, 15, 17, 19.
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Kashmir valley 6.1% (2000)(12)
New Delhi-10.3% (2001)(13)
Jaipur 8.6% (2003)(15)
Mumbai 9.3% (2001)(13)
Bengaluru-12.4% (2001)(13)
Ernakulam- 19.5% (2006)(17)
Thriuvananthapuram- 16.3% (1999)(10)
Chennai 13.5% (2001)(13)
14.3% (2006)(19)
Hyderabad-16.6% (2001)(13)
Kolkatta 11.7%(2001)(13)
Guwahati 8.3%(1999)(11)
* numbers in parentheses denote references
Diabetes and Endocrine Population Survey
(ADEPS)17, a community based cross-sectional
survey done in urban areas of Ernakulam district in
Kerala has revealed a very high prevalence of 19.5
per cent. Fig. 2 is a map of India showing the States
where population-based studies have been done and
it also shows the prevalence of type 2 diabetes
reported in different regions of India.
Chennai Urban Rural Epidemiology Study
(CURES)
Further support for the rising prevalence of
diabetes comes from the results obtained from the
Chennai Urban Rural Epidemiology Study
(CURES)18. This study was conducted on a
representative population of Chennai. The sampling
for CURES was based on the model of systematic
random sampling, wherein of the 155 wards of the
corporation of Chennai, 46 were selected to represent
all the 10 zones. A total of 26,001 individuals were
selected from these 46 wards for the Phase 1 of
CURES and a fasting capillary glucose measurement
was obtained in all. Phase 2 focused on the study of
complications of diabetes in the self-reported diabetic
subjects identified in Phase 1, while Phase 3 recruited
every tenth subject (n=2600) screened in Phase 1 for
an oral glucose tolerance test. Phase 3 had a response
rate of 90.4 per cent (i.e., 2350/2600 subjects
participated).
This study gave us a unique opportunity to
compare prevalence rates of diabetes in Chennai city
which is the only region in India that has had repeated
well-conducted epidemiology studies on prevalence
of diabetes over the past two decades. We were thus
able to compare the data obtained from CURES with
three earlier epidemiological studies8,9,13 carried out
in the same city using similar methods.
The overall crude prevalence of diabetes using
WHO criteria14 in CURES was 15.5 per cent (age-
standardized: 14.3%), while that of IGT was 10.6
per cent (age-standardized: 10.2%). From 1989 to
1995, the prevalence of diabetes in Chennai
increased by 39.8 per cent (8.3 to 11.6%); between
1995 to 2000 by 16.3 per cent (11.6 to 13.5%) and
between 2000 to 2004, by 6.0 per cent (13.5 to
14.3%). Thus within a span of 14 yr, the prevalence
of diabetes increased significantly by 72.3 per cent
(P<0.001). Fig. 3 shows the prevalence of diabetes
in different age groups as reported by the CURES.
The prevalence of diabetes seems to be more or less
the same in both genders13.
Fig. 3. Prevalence of diabetes in different age groups in Chennai-The Chennai urban rural epidemiology study (CURES)18.
Source : Ref. 19.
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Shift in age of onset of diabetes: The CURES19 also
reported a temporal shift in the age at diagnosis to a
younger group when compared to the NUDS study
published just five years earlier13 (Fig. 4). This is a
disturbing finding as the earlier age of onset
combined with increasing prevalence of diabetes
could have adverse effects on nation’s health and
economy. A study from Delhi also reports a high
prevalence of insulin resistance in post pubertal
children which was associated with excess body fat
and abdominal adiposity20. This is of great concern
because if the epidemic shifts to children it could
have serious consequences on the health of the nation.
Undiagnosed diabetes - the hidden danger
It is important to note that the studies that have
shown an increase in prevalence of diabetes have also
reported a very high prevalence of undiagnosed
diabetes in the community. While in CURES, the
prevalence of known diabetes was 6.1 per cent, that
of undiagnosed diabetes was 9.1 per cent19. Similarly,
in the ADEPS, the prevalence of known and
undiagnosed diabetes were 9.0 and 10.5 per cent
respectively17. The Kashmir valley study showed that
the prevalence of undiagnosed diabetes was 4.25 per
cent, which was more than double to that of the
known diabetes (1.9%)12. The individuals who are
unaware of their disease status are left untreated and
are thus more prone to microvascular as well as
macrovascular complications. Hence, it is necessary
to detect the large pool of undiagnosed diabetic
subjects in India and offer early therapy to these
individuals.
Urban-rural differences in diabetes prevalence
Urban rural differences in the prevalence of
diabetes has been consistently reported from India.
While the ICMR study reported that the prevalence
was 2.1 per cent in urban and 1.5 per cent in rural
areas4, a later study showed that the prevalence was
three times higher among the urban (8.2%) compared
to the rural population (2.4%)8. A study done in
southern Kerala looked at the variations in the
prevalence of type 2 diabetes among different
geographic divisions within a region21. The
prevalence of diabetes was the highest in the urban
(12.4%) areas, followed by the midland (8.1%),
highland (5.8%) and coastal division (2.5%).
Fig. 4. Temporal shift in age at diagnosis of diabetes in 2004 (CURES-dotted line) compared to 2000 (NUDS-thick line).
Source: Ref. 13, 19.
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The prevalence of diabetes in India study (PODIS):
This study was carried out in 108 centres (49 urban
and 59 rural) to look at the urban-rural differences
in the prevalence of type 2 diabetes and glucose
intolerance22. Capillary blood was used to estimate
glucose levels and glucose intolerance was defined
according to the WHO 1999 as well as the American
Diabetes Association (ADA) 1997 criteria22,23.
According to the ADA criteria, the prevalence of
diabetes was 4.7 per cent in the urban compared to
the 2.0 per cent in the rural population while the
prevalence of diabetes according to the WHO criteria
was 5.6 and 2.7 per cent among urban and rural areas
respectively.
The WHO-ICMR national NCD risk factor
surveillance
In order to obtain continuous surveillance of
NCD risk factors in India, the WHO and the ICMR
took up NCD Risk Factor Surveillance in five States
of India, representing different geographical
locations (north, south, east and west/central
India)24,25. About 40,000 individuals aged 15 to 64 yr
with equal representation from urban, peri-urban
(slum) and rural areas were recruited for the study24.
The overall frequency of self reported diabetes study
was 4.5 per cent. Urban area had the highest
prevalence (7.3%), followed by peri-urban/slum
(3.2%) and rural areas (3.1%).
Prediabetes- the harbinger of future diabetes
Impaired glucose tolerance (IGT) and impaired
fasting glucose (IFG) collectively called as pre-
diabetic states, have a high risk of conversion to
diabetes. Several studies have shown that these pre-
diabetic states are also high risk stages for
cardiovascular disease26,27. Hence data on IGT and
IFG are also urgently needed as they are indicators
of future diabetes prevalence and burden on the
nation. The NUDS results indicate that the prevalence
of IGT was higher than that of type 2 diabetes in
four out of six cities studied13. The prevalence of IGT
was 16.8 per cent in Chennai, 14.9 per cent in
Bengaluru (formerly Bangalore), 29.8 per cent in
Hyderabad, 10 per cent in Kolkatta, 10.8 per cent in
Mumbai and 8.6 per cent in New Delhi. The ADEPS
done in Kerala showed that 11.2 per cent of the
subjects had either IFG or IGT17. The PODIS reported
that the prevalence of IGT was significantly high in
both rural and urban populations22. A recent study
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Fig. 5. Prevalence of impaired glucose tolerance at Chennai. Source: Ref. 8, 9, 13, 19.
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has reported a decreased prevalence of IGT in an
urban population compared to earlier studies done
in the same city19 (16.8% in 2000 to 10.2% in 2004)
(Fig. 5). This could suggest that the diabetes epidemic
in urban India may be slowing down or it may also
suggest that there could be a rapid progression from
the normal state through IGT to diabetes, which could
imply a rapid increase in the diabetes epidemic or a
worsening diabetogenic environment.
Burden of diabetes related complications in India
Both macrovascular and microvascular
complications cause significant morbidity and
mortality among diabetic subjects28. The Chennai
Urban Population Study (CUPS) and CURES
provided valuable data from India on the
complications related to diabetes. The prevalence of
coronary artery disease was 21.4 per cent among
diabetic subjects compared to 9.1 per cent in subjects
with normal glucose tolerance29. The prevalence of
CAD in IGT subjects were 14.9 per cent in the same
study. It was also seen that the diabetic subjects had
increased subclinical atherosclerosis as measured by
intimal medial thickness (IMT) at every age point
compared to subjects with normal glucose tolerance30.
A recent study showed that carotid intima medial
thickness increased with worsening grades of glucose
tolerance as well as with increase in the number of
components of metabolic syndrome31. The prevalence
of peripheral vascular disease (PVD) was 6.3 per cent
among diabetic subjects compared to 2.7 per cent in
non-diabetic subjects32, and these figures are lower
than the prevalence reported in western populations33.
This is probably due to lower age at onset for
diagnosis of type 2 diabetes in India. It is well known
that PVD is more common in older individuals. The
CURES Eye study is the largest population based data
on the prevalence of diabetic retinopathy done in
India. This study showed that the overall prevalence
was 17.6 per cent, which was lower when compared
to the reports from the West34. A recent population
based study reported that the prevalence of overt
nephropathy was 2.2 per cent in Indians while
microalbuminuria was present in 26.9 per cent.
Glycated haemoglobin, duration of diabetes and
systolic blood pressure were independently
associated with diabetic nephropathy35. Overall,
Asian Indians appear to have a greater predilection
for cardiovascular complications whereas the
Fig. 6. Differences in mortality rates among diabetic and non-diabetic individuals - the Chennai urban population
study (CUPS). Source: Ref. 36.
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prevalence of microvascular complications appears
to be lower than in Europeans.
A recent follow up of the original CUPS cohort
showed that the overall mortality rates were nearly
three-fold higher (18.9 per 1000 person-years) in
people with diabetes compared to non diabetic
subjects (5.3 per 1000 person-years, P=0.004)36. The
hazard ratio (HR) for all cause mortality for diabetes
was found to be 3.6 compared to non diabetic
subjects. The study also showed that mortality due
to cardiovascular (diabetic subjects: 52.9% vs. non
diabetic subjects 24.2%, P=0.042) and renal (diabetic
subjects 23.5% vs. non diabetic subjects 6.1%,
P=0.072) causes was higher among diabetic subjects
(Fig. 6).
Causes of the rise in prevalence of diabetes
Genetic predisposition: Several studies on migrant
Indians across the globe have shown that Asian
Indians have an increased risk for developing type 2
diabetes and related metabolic abnormalities
compared to other ethnic groups37-39. Although the
exact reasons are still not clear, certain unique
clinical and biochemical characteristics of this ethnic
group collectively called as the “Asian Indian
phenotype” is considered to be one of the major
factors contributing to the increased predilection
towards diabetes40,41.  Despite having lower
prevalence of obesity as defined by body mass index
(BMI), Asian Indians tend to have greater waist
circumference and waist to hip ratios42 thus having a
greater degree of central obesity. Again, Asian
Indians have more total abdominal and visceral fat
for any given BMI43 and for any given body fat they
have increased insulin resistance44. Moreover, they
have lower levels of the protective adipokine
adiponectin and have increased levels of adipose
tissue metabolites45. Studies on neonates suggested
that Indian babies are born smaller but relatively
fatter compared to Caucasian babies and are referred
to as “the thin fat Indian baby”46,47. A recent study
confirmed this finding and suggested that the “thin
fat phenotype” in neonates persisted in childhood and
could be a forerunner of the diabetogenic adult
phenotype48. These findings suggest that Asian
Indians are more prone to diabetes and related
metabolic abnormalities. Genetic factors that
determine body fat distribution and glucose
metabolism have to be fully elucidated for the better
understanding of the biochemical and molecular
mechanisms behind the aetiopathogenesis of
diabetes. Our studies have shown that while some
genes seem to confer increased susceptibility to
diabetes in Indians49,50, some protective genes in
Europeans do not appear to protect Indians51. These
genetic issues are discussed elsewhere in the same
issue52.
The epidemiological transition
The dramatic rise in the prevalence of type 2
diabetes and related disorders like obesity,
hypertension and the metabolic syndrome could be
related to the rapid changes in life style that has
occurred during the last 50 yr. Although this
“epidemiological transition”, which includes
improved nutrition, better hygiene, control of many
communicable diseases and improved access to
quality healthcare have resulted in increased
longevity, it has also led to the rapid rise of the new-
age diseases like obesity, diabetes and heart disease.
The intrusion of western culture into the lives of
traditional indigenous communities has also had
devastating results in terms of the rise in diabetes
and related metabolic disorders. The explosion of
type 2 diabetes in Native American and Pacific Island
communities are classical examples of this
phenomenon. Another way to explain the diabetes
epidemic in these and other ethnic groups like
Africans and Asian Indians is through Neel’s ‘thrifty
genotype’ hypothesis53. This hypothesis proposes that
some genes are selected over previous millennia to
allow survival in times of famine by efficiently
storing all available energy during times of feast.
However, these very genes lead to obesity and type
2 diabetes when exposed to a constant high energy
diet. In virtually all populations, higher fat diets and
decreased physical activity and sedentary
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occupational habits have accompanied the process
of modernization which has resulted in the doubling
of the prevalence of obesity and type 2 diabetes in
less than a generation.
Increase in the prevalence of type 2 diabetes may
also result due to migration (a move from one
environment to another, either external or internal),
which brings with it marked social and cultural
changes. Misra and colleagues54 reported that
migration from rural areas to urban slums in a
metropolitan city in India led to obesity, glucose
intolerance, and dyslipidaemia. Many
epidemiological studies on diabetes in migrant
populations, mostly in people originating from
developing countries, have reported a higher
prevalence of diabetes than the host populations of
those countries.
‘Fast food culture’ and ‘Sedentarinism’- The main
drivers of diabetes epidemic in India
In order to assess the effect of affluence on the
prevalence of diabetes in India, we undertook a
population-based study in urban south Indians called
the Chennai Urban Population Study (CUPS)55.
Briefly, the CUPS is a population-based study
involving two residential areas representing the lower
and middle income group in Chennai (formerly
Madras) in south India. All individuals aged more
than 20 yr living in these two colonies were requested
to participate in the study. Of the total of 1399
eligible subjects (age >20 yr), 1262 (90.2%)
participated in the study. The study subjects
underwent a glucose tolerance test (GTT) and were
categorized as having normal glucose tolerance
(NGT), IGT or diabetes.
The overall prevalence of diabetes was 12 per
cent in the population above the age of
20 yr56. The age-standardized prevalence rate of
diabetes was significantly higher in the middle
income group compared to the lower income group
(12.4 vs 6.5%, respectively). The prevalence of
obesity and other cardiovascular risk factors were
also markedly higher in the middle income group
than the low income group. Moreover, the ‘fast food
culture’ which has overwhelmed our cities and towns
is also a major driver of the diabetes epidemic. The
‘fast-foods’ that are fat and calorie rich are easily
available in the numerous food joints. As a majority
of the immigrants in Indian cities depend on these
unhealthy ‘junk’ foods, this may be a major factor in
the rising prevalence of diabetes and cardiovascular
diseases in urban slums. One point worth
emphasizing is that diabetes can no longer be
considered as a disease of the rich. The prevalence
of diabetes is now rapidly increasing among the poor
in the urban slum dwellers, the middle class and even
in the rural areas. This is due to rapid changes in
physical activity and dietary habits even among the
poorer sections of the society. Unfortunately the poor
diabetic subjects delay taking treatment leading to
increased risk of complications57. Moreover, as the
epidemic matures and reaches the next stage of
transition, the rich and affluent will rapidly change
their activity patterns and start making healthier food
choices and ultimately the diabetes and heart disease
will decrease in this section of the society. This has
been demonstrated in the developed world where the
prevalence of diabetes and cardiovascular diseases
are higher among the lower socio-economic group
and in rural areas compared to higher socio-economic
group and urban areas58-60.
The next factor driving the epidemic is what has
been referred to as ‘sedentarinism’ or the adoption of
sedentary behaviour. Over the past few decades, a huge
number of the working population has shifted from
manual labour associated with the agriculture sector
to physically less demanding office jobs. With the
advent of highly addictive computer and video games,
sedentarinism is now affecting the children and youth
as they tend to spend more time in front of television
sets or computers than playing outdoors. The evidence
for the effects of physical inactivity on the prevalence
of diabetes and cardiovascular diseases can be seen in
CUPS61,62. It was observed that the prevalence of
diabetes was almost three times higher in individuals
with light physical activity compared to those having
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heavy physical activity (23.2 vs. 8.1%, P<0.001)61. It
was also noted that prevalence of metabolic syndrome
and hypertension was also significantly higher among
people with light physical activity62. Overall,
individuals with light-grade physical activity had 2.4
times higher chances of developing coronary artery
disease compared to heavy grade physical activity
group62. Hence early identification of the risk factors
associated with diabetes and appropriate interventions
aimed at preventing the onset of diabetes and its
complications are urgently required.
Early identification and prevention - the Indian
diabetes risk score (IDRS)
Several prospective studies have shown that
measures of lifestyle modification help in preventing
the onset of diabetes63-65. The Indian Diabetes
Prevention Programme (IDPP), a preventive study
done in India based on the Diabetes Prevention
Program (DPP) has clearly documented the
importance of physical activity in the prevention of
diabetes66. Early identification of the high risk
individuals would help in taking appropriate
intervention in the form of dietary changes and
increasing physical activity, thus helping to prevent,
or at least delay, the onset of diabetes. This means
that identification of at risk individuals is extremely
important if we are to prevent diabetes in India.
Recently, risk scores based on simple anthropometric
and demographic variables have been devised to
detect high risk individuals67,68. But it is also evident
that a common risk score cannot be applied for all
ethnic groups69. Hence ethnic specific risk scores are
extremely important in identification of at risk
individuals in a particular ethnic group.
We have recently developed the Indian Diabetes
Risk Score (IDRS) using four simple variables
namely, age, family history, regular exercise and
waist circumference70 (Table). The individuals were
classified as having high risk (score >60), moderate
risk (score 30-50) and low risk (score <30) out of a
total score of 100.  IDRS has a sensitivity and
specificity of over 60 per cent for a cut-off >60 and
can be used to do a selective screening for Indian
population. A recent study showed that IDRS not only
predicted diabetes, but also identified individuals
with higher cardiovascular risk i.e., those with
metabolic syndrome even at a stage when they have
normal glucose tolerance71. This simple and cost-
effective IDRS could thus serve as a tool for a
primary care physician or a health worker to identify
at risk individuals for both diabetes and
cardiovascular diseases.
Diabetes prevention through community
empowerment
The CURES has demonstrated that the awareness
about diabetes in urban areas is extremely low72.
Nearly 25 per cent of the residents were not even
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Table. Indian Diabetes Risk Score (IDRS)
Particulars Score
Age (yr):
< 35 (reference)  0
35-49 20
>50 30
Abdominal obesity:
Waist <80 cm (female), <90 (male) (reference)  0
Waist > 80-89 cm (female), >90-99 cm (male) 10
Waist >90 cm (female), >100 cm (male) 20
Physical activity:
Vigorous exercise or strenuous (manual)
labour at home/work  0
Mild to moderate exercise or mild to
moderate physical activity at home/work 20
No exercise and sedentary activities
at home/work 30
Family history:
No family history (reference)  0
Either parent 10
Both parents 20
Minimum score  0
Maximum score 100
Interpretation: Score < 30 low risk, score 30-50 medium risk
and score > 60 high risk for type 2 diabetes and cardiovascular
diseases
Source: Modified from Ref. 70
aware of a condition called diabetes. Moreover, even
among the diabetic subjects, the knowledge and
awareness about complications was poor and less
than 50 per cent knew that diabetes in preventable.
A recent study has shown how increasing
awareness and empowerment of community can
possibly help in the prevention of diabetes and other
non communicable disorders72. Mass awareness
programmes like public lectures, video clippings and
distribution of educational pamphlets were carried
out in a residential colony in Chennai for three years
continuously. A follow up study was done
7 yr after the baseline study. It was found that there
was a 277 per cent increase in the proportion of
walkers from baseline to follow up. The proportion
of individuals who exercised increased from 14.2 to
58.7 per cent73. The colony residents motivated by
the awareness programmes constructed a park with
the help of civic authorities which is being now used
regularly not only by the residents but also by
neighbouring colonies.
Prevention Awareness Counseling and Evaluation
(PACE) Diabetes programme is a large awareness and
prevention programme underway in Chennai74. The
aim of this programme which is funded by the Chennai
Willingdon Corporate Foundation, a non governmental
organization (NGO) in Chennai, is to create massive
public awareness about diabetes and related disorders
reaching out to about a million people and conduct
large scale opportunistic screening of at least 100,000
people. Awareness programmes are being organized
in public places like banks, shopping complexes,
cinema halls, places of worship, bus stands, railway
stations, schools, colleges, etc. The PACE project is
already having a large impact in the form of increased
diabetes awareness. Mass awareness programmes not
only help in the prevention of diabetes, but also help
in increasing the awareness about other non
communicable diseases.
In conclusion, the past decades have witnessed a
rapid rise in the prevalence of diabetes, especially in
the urban areas. The fact that there is a shift in age
of onset to younger age groups is alarming as this
could have adverse effects on the nation’s economy.
Hence, the early identification of at risk individuals
and appropriate intervention in the form of weight
reduction, changes in dietary habits and increased
physical activity could greatly help to prevent, or at
least delay, the onset of diabetes and thus reduce the
burden due to non communicable diseases in India.
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